<SEC-DOCUMENT>0001209191-23-005349-index.html : 20230127
<SEC-HEADER>0001209191-23-005349.hdr.sgml : 20230127
<ACCEPTANCE-DATETIME>20230127181835
ACCESSION NUMBER:		0001209191-23-005349
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20221114
FILED AS OF DATE:		20230127
DATE AS OF CHANGE:		20230127

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Neuman Linda L
		CENTRAL INDEX KEY:			0001951205

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37722
		FILM NUMBER:		23564706

	MAIL ADDRESS:	
		STREET 1:		C/O AEGLEA BIOTHERAPEUTICS, INC.
		STREET 2:		805 LAS CIMAS PARKWAY, SUITE 100
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aeglea BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001636282
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				464312787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		805 LAS CIMAS PARKWAY
		STREET 2:		SUITE 100
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
		BUSINESS PHONE:		(512) 942-2935

	MAIL ADDRESS:	
		STREET 1:		805 LAS CIMAS PARKWAY
		STREET 2:		SUITE 100
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
Document 1 - file: doc3.html

Document 1 - RAW XML: doc3.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>poa.txt
<DESCRIPTION>POA DOCUMENT
<TEXT>
Document 2 - file: poa.txt

</DOCUMENT>
</SEC-DOCUMENT>